[PERSON]
Paudie Coady
Featured in 1 tracked story · first seen
Situations
HSE approves Skyclarys reimbursement for patients
5 clusters · 12 sources · last updated
Latest: HSE approves Skyclarys reimbursement for Friedreich’s Ataxia patients
The HSE Drugs Group had previously recommended against state funding for Skyclarys, a treatment for Friedreich’s ataxia, citing high costs of approximately €280,000 per patient annually. While the drug is approved by the